Baxter International (BAX) Non-Current Debt (2009 - 2026)
Baxter International (BAX) posted quarterly Non-Current Debt of $8.6 billion for Q2 2026, down 9.24% year-over-year from $9.5 billion in Q2 2025, and little changed quarter-over-quarter from $8.6 billion in Q1 2026.
Baxter International (BAX) Non-Current Debt (2009 - 2026) Analysis & Trends
Baxter International (BAX) has reported Non-Current Debt for 18 consecutive years, with $8.6 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Non-Current Debt fell 9.24% year-over-year to $8.6 billion; the TTM figure through Jun 2026 stood at $8.6 billion (down 9.24% YoY), while the FY2025 annual figure was $9.5 billion, down 8.69% from the prior year.
- Non-Current Debt steadied at $8.6 billion in Q2 2026 per BAX's latest filing, from $8.6 billion in the prior quarter.
- Across five years, Non-Current Debt topped out at $16.2 billion in Q3 2022 and bottomed at $175.0 million in Q1 2022.
- Historically, Non-Current Debt has averaged $10.2 billion across 5 years, with a median of $10.4 billion in 2024.
- Annual changes were most pronounced in 2023 — Non-Current Debt surged 8630.29% — and 2024, when it declined 27.4%.
- Baxter International's Non-Current Debt stood at $15.2 billion in 2022, then dropped by 27.2% to $11.1 billion in 2023, then declined by 6.45% to $10.4 billion in 2024, then declined by 8.69% to $9.5 billion in 2025, then fell by 9.06% to $8.6 billion in 2026.
- Business Quant data shows BAX's Non-Current Debt at $8.6 billion in Q2 2026, $8.6 billion in Q1 2026, and $9.5 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 13.51 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 4.15 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 399.42 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 12.55 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 202.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 4.57 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 1.86 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 8.62 Bn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.62 Bn |
| Mar 31, 2026 | 8.62 Bn |
| Dec 31, 2025 | 9.47 Bn |
| Sep 30, 2025 | 8.75 Bn |
| Jun 30, 2025 | 9.49 Bn |
| Mar 31, 2025 | 9.41 Bn |
| Dec 31, 2024 | 10.37 Bn |
| Sep 30, 2024 | 10.44 Bn |
| Jun 30, 2024 | 10.44 Bn |
| Mar 31, 2024 | 11.09 Bn |
| Dec 31, 2023 | 11.09 Bn |
| Sep 30, 2023 | 14.07 Bn |
| Jun 30, 2023 | 14.31 Bn |
| Mar 31, 2023 | 15.28 Bn |
| Dec 31, 2022 | 15.23 Bn |
| Sep 30, 2022 | 16.15 Bn |
| Jun 30, 2022 | 355.00 Mn |
| Mar 31, 2022 | 175.00 Mn |
| Dec 31, 2021 | 17.15 Bn |
| Dec 31, 2020 | 5.79 Bn |